Repligen Corp (RGEN)

Is Repligen Corp (RGEN) A Buy Now?

According to our latest analysis, RGEN could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RGEN, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 46.59 indicates that RGEN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 62.67 indicates that RGEN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.60 indicates that RGEN is oversold. This suggests that RGEN price is at or near the lowest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 17.51 suggests that there may be some movement in price, but it lacks strength or conviction.
5. CCI (Commodity Channel Index): A CCI(14) value of -77.64 indicates that RGEN is still oversold but not to an extreme extent.

Long-term RGEN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Repligen Corp financial reports and earnings history, Repligen Corp (RGEN) stock could reach $112.35 by 2030, $94.43 by 2040 and $280.44 by 2050. See the projected annual prices until 2050 of the Repligen Corp stock below:

• Repligen Corp (RGEN) is expected to reach an average price of $7.00 in 2035, with a high prediction of $59.29 and a low estimate of $0.0464. This indicates an -95.98% change from the last recorded price of $174.12.
• Repligen Corp (RGEN) stock is projected to chart a bullish course in 2040, with an average price target of $56.71, representing an -67.43% change from its current level. The forecast ranges from a conservative $32.07 to a sky-high $94.43.
• Our analysts predict Repligen Corp (RGEN) to change -8.62% by 2045, soaring from $139.67 to an average price of $159.12, potentially reaching $174.15. While $139.67 is the low estimate, the potential upside is significant.
• Repligen Corp (RGEN) stock is expected to climb by 2050, reaching an average of $220.35, a +26.55% change from its current level. However, a wide range of estimates exists, with high and low targets of $280.44 and $182.71, respectively, highlighting the market's uncertainty.

Repligen Corp Stock (RGEN) Year by Year Forecast